Praesidian Capital Successfully Exits Investment in Biologos
Oklahoma City – March 21, 2024 – Praesidian Capital, a private equity firm headquartered in Oklahoma City with offices in New York and London, announced the successful exit of its investment in Biologos Holdings, LLC (“Biologos”), a provider of sterile-filtered biological products for veterinary, pharmaceutical, and medical research applications. Praesidian made an initial investment in…